News

Adam Beck, an executive at America's Health Insurance Plans, said he'd rather see tweaks than major changes.

"It's likely that every broker’s book of business contains groups where ICHRA could meet specific needs effectively,” the report said.

The American Diabetes Association has issued a guidance statement that cautions against using compounded versions of popular GLP-1 diabetes and weight-loss drugs such as Wegovy and Zepbound.

Karen DeSalvo hopes users will be comfortable, but not too comfortable, with new navigation tools.

Dr. Vin Gupta says same-day prescription delivery might increase the odds that patients will take their medicine.

The CEO of a next-gen PBM is not sure he'll like government efforts to rein in his giant competitors.